Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma

Fig. 5

Comprehensive analysis of the differences in immune response genes between high-risk and low-risk patients in the training cohort. A and B Comparison of the CYT score (A), GZMA expression and PRF1 expression (B) between high-risk and low-risk patients in the training cohort. C Comparison of immune checkpoint expression (CD274, HAVCR2 and IDO1) between high-risk and low-risk patients in the training cohort. D Comparison of costimulatory and MHC molecule expression between high-risk and low-risk patients. E Comparison of chemokine expression between high-risk and low-risk patients

Back to article page